Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People with Diabetes: The Need for Screening and Early Intervention. a Consensus Report of the American Diabetes Association

Authors

Kenneth Cusi
Manal F. Abdelmalek
Caroline M. Apovian
Kirthikaa Balapattabi
Raveendhara R. Bannuru
Diana Barb
Joan K. Bardsley
Elizabeth A. Beverly
Karen D. Corbin
Nuha A. ElSayed
Scott Isaacs
Fasiha Kanwal
Elizabeth J. Pekas
Caroline R. Richardson
Michael Roden
Arun J. Sanyal
Jay H. Shubrook, Touro University CaliforniaFollow
Zobair M. Younossi
Mandeep Bajaj

Roles

Author

Document Type

Article

Publication Date

1-1-2025

Publication Title

Diabetes Care

DOI

10.2337/dci24-0094

Recommended Citation

Cusi, K., Abdelmalek, M. F., Apovian, C. M., Balapattabi, K., Bannuru, R. R., Barb, D., Bardsley, J. K., Beverly, E. A., Corbin, K. D., ElSayed, N. A., Isaacs, S., Kanwal, F., Pekas, E. J., Richardson, C. R., Roden, M., Sanyal, A. J., Shubrook, J. H., Younossi, Z. M., & Bajaj, M. (2025). Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People with Diabetes: The Need for Screening and Early Intervention. a Consensus Report of the American Diabetes Association. Diabetes Care, 48 (7), 1057-1082. https://doi.org/10.2337/dci24-0094